Search results
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 4 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...
Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoAffimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript June 12, 2024 Affimed N.V. beats...
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL...
Morningstar· 4 days agoAmgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with ...
'I learned the hard way': Man issues warning after he was told he was perfectly healthy during...
The Daily Dot· 6 days agoMark (@mendandthrive) uses his TikTok platform to promote cancer awareness and self-advocacy to his...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 5 days agoKnown as chimeric antigen receptor (CAR) T-cell therapy, the treatment involves harvesting a...